Mumbai, India | April 20th, 2026: Rusan Pharma, a leading pharmaceutical company pioneering pain management, movement disorder, and addiction solutions worldwide, has achieved a significant global regulatory milestone with the successful Good Manufacturing Practice (GMP) approvals from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA). This
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025 Venus Remedies is targeting the $237-million antibiotic market in GCC region, out of which 35 per cent accounts for
India Pharma & India Medical Device 2023 aims to position India as a leading international healthcare hub and attract investments. The Union Minister of Health & Family Welfare and Chemicals & Fertilizers, Dr Mansukh Mandaviya today said, “There is a need to harness India's vast potential in the
